Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma (Q34386179)

1 August 2017

1 reference

title

Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

L S Schwartzberg

1

1 reference

1 August 2017

publication date

1 October 2001

1 reference

Critical Reviews in Oncology Hematology

1 August 2017

published in

1 reference

1 August 2017

volume

40

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

17-24

1 reference

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Colorectal carcinoma antigens detected by hybridoma antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Tumor-associated antigen expression of primary and metastatic colon carcinomas detected by monoclonal antibody 17-1A

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

The biology of the 17-1A antigen (Ep-CAM)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Phase II multicenter evaluation of prolonged murine monoclonal antibody 17-1A therapy in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma--long-lasting, complete remissions can be induced

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900131-7

7 January 2021

10.1016/S1040-8428(01)00131-7

Identifiers

DOI

1 reference

1 August 2017

1 reference